Weill Cornell Medical College Sandra & Edward Meyer Cancer Center | Strategic Alliance Partners

May 17, 2023

An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.

May 17, 2023

A comprehensive overview of treatment approaches for patients with high-risk melanoma.

May 10, 2023

Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.

May 10, 2023

A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.

May 05, 2023

Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.

May 03, 2023

An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.

May 03, 2023

Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.

April 28, 2023

Looking toward the future management of HER2-amplified colorectal cancer, panelists reflect on ongoing clinical trials and evolving treatment strategies.

April 28, 2023

Expert perspectives on the real-world use of HER2-directed therapies in patients with HER2-amplified colorectal cancer.

April 26, 2023

Expert oncologists look to the future of treatment for cutaneous squamous cell carcinoma.

April 26, 2023

Skin cancer expert Anna C. Pavlick, DO, discusses treatment duration approaches for cutaneous squamous cell carcinoma.

April 21, 2023

A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.

April 21, 2023

Broadening their conversation, expert oncologists define the treatment algorithm for patients diagnosed with colorectal cancer.

April 19, 2023

Nikhil Khushalani, MD, gives a comprehensive overview of cemiplimab and pembrolizumab for treating CSCC.

April 19, 2023

Anna C. Pavlick, DO, overviews systemic therapy options for patients with unresectable or metastatic CSCC.

April 14, 2023

In the context of colorectal cancer clinical trials, panelists reflect on the role of liquid biopsies to help inform treatment decisionmaking.

April 14, 2023

A brief review of HER2 amplification and how it may impact the treatment pathway for patients with a diagnosis of colorectal cancer.

April 12, 2023

Nikhil Khushalani, MD, discusses the multidisciplinary team approach to treating patients with cutaneous squamous cell carcinoma.

April 12, 2023

Skin cancer experts discuss prognosis and unmet needs in the cutaneous squamous cell carcinoma and melanoma treatment spaces.

April 03, 2023

Anna C. Pavlick, DO, discusses the mechanism of action of vusolimogene oderparepvec in patients with anti–PD-1–failed cutaneous melanoma.